pipobroman has been researched along with cyclosporine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Bouscary, D; Casadevall, N; Dreyfus, F; Fontenay-Roupie, M; Jondeau, K; Quarre, MC; Vassilief, D; Viguié, F; Zompi, S | 1 |
| Ferrant, A; Straetmans, N; Triffet, A | 1 |
1 review(s) available for pipobroman and cyclosporine
| Article | Year |
|---|---|
Bone marrow aplasia after pipobroman: an immune-mediated mechanism?
Topics: Aged; Aged, 80 and over; Anemia, Aplastic; Antineoplastic Agents, Alkylating; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Middle Aged; Pipobroman; Thrombocythemia, Essential | 2001 |
2 other study(ies) available for pipobroman and cyclosporine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Aplastic anemia responsive to cyclosporine complicating the evolution of polycythemia vera.
Topics: Anemia, Aplastic; Antineoplastic Agents, Alkylating; Cyclosporine; Humans; Immunosuppressive Agents; Male; Middle Aged; Pipobroman; Polycythemia Vera | 1999 |